Understanding investment barriers in the UK MedTech ecosystem

MedTech innovations have the potential to reduce NHS waiting lists and address healthcare challenges, but SMEs often face high costs and limited regulatory expertise, making market entry difficult. The MedTech Accelerator: Rapid Regulatory Support (MARRS), funded by the Office for Life Sciences, has already supported 142 SMEs with regulatory guidance grants of up to £30,000. This report builds on extensive engagement with around 150 SMEs, 40 investors, and wider ecosystem stakeholders to explore barriers to investment in the UK MedTech sector. Drawing on these insights, it outlines key challenges and provides recommendations for policy action, stakeholder behaviours, and new initiatives to help strengthen investment and support SME growth.